3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Genitourinary
1
Conditions
Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Pancreatic Cyst
1
Disease
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Gastric Carcinoma
1
Interventions
pembrolizumab
38
Blood Specimen Collection
38
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
17
Exercise
17
Carboplatin
17
Nivolumab
15
atezolizumab
14
Paclitaxel
14
Cisplatin
14
Drug Therapy
13
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
11
Trastuzumab
10
Pemetrexed
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Defecation
×
Clear all
NCT04970472
2026-03-19
MicroBlad
University Hospital, Toulouse
Recruiting
1,000 enrolled
NCT04567446
2024-06-12
ONCOBIOTICS
Gustave Roussy, Cancer Campus, Grand Paris
Recruiting
1,100 enrolled